Quality by Design is “a systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management.” (ICH Q8)
This course provides a structured approach to explore the development of a risk-based, data driven control strategy for the manufacture of pharmaceutical products and processes.
All lectures are delivered by experts from industry using our online platform. You can access the learning material at anytime from anywhere in the world.
Student support and access to learning material is all online. The course aims to improve your approach to pharmaceutical product development and enhance your employability skills and career prospects.
Who should attend the course?
This course has been designed for graduates and postgraduates (biologists, chemists, chemical engineers, pharmacists, physicists, material scientists) who aspire to learn more about developing and manufacturing medicines using Quality by Design principles.
Reasons to study Quality by Design for the Pharmaceutical Industry at DMU:
- High employability
- Job opportunities nationally and internationally
- Aligned with international regulatory framework
- Recognised by multinational companies